SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Zafgen, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of December 21, 2015 -- ZFGN
(firmenpresse) - NEW YORK, NY -- (Marketwired) -- 10/30/15 -- The following statement is being issued by Levi & Korsinsky, LLP:
("Zafgen") (NASDAQ: ZFGN) .
that a securities class action lawsuit has been commenced in the USDC for the District of Massachusetts. To get more information :
or contact Joseph E. Levi, Esq. either via email at or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
The lawsuit alleges that Defendants made misrepresentations about thrombotic adverse events in previous clinical trials of its anti-obesity drug, and leading drug candidate, beloranib. Until October 16, 2015, Zafgen had disclosed only two thrombotic adverse events in one prior clinical trial.
On October 14, 2015, Zafgen issued a statement acknowledging the death of a patient in its ongoing Phase 3 study of beloranib. On October 15, 2015, the Food and Drug Administration informed Zafgen that beloranib had been placed on partial clinical hold. Then on October 16, 2015, Zafgen announced that: (i) the patient who died was receiving beloranib -- not a placebo; and (ii) there had been four thrombotic adverse events in prior clinical studies of beloranib -- two more than previously reported -- as well as two additional, previously undisclosed thrombotic events in ongoing studies.
to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 30.10.2015 - 18:47 Uhr
Sprache: Deutsch
News-ID 430846
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Legal
Diese Pressemitteilung wurde bisher 209 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Zafgen, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of December 21, 2015 -- ZFGN"
steht unter der journalistisch-redaktionellen Verantwortung von
Levi & Korsinsky, LLP (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
